“`html BREAKING: sotatercept Cuts PAH Mortality Risk BREAKING: Sotatercept Cuts PAH Mortality Risk By Amelia Stone | SAN FRANCISCO – 2025/05/30 15:46:49 sotatercept (Winrevair; Merck) is demonstrating a… The post Sotatercept PAH: Long-Term Safety & Mortality Benefit appeared first on NewsyList. Source link
A relatively new therapy used to treat pulmonary arterial hypertension in those with mild to moderate disease was found to be effective at preventing death in those with more advanced disease. Results were published on Wednesday, May 28, in The New England Journal of Medicine and could have “transformative implications” for patients, according to an … Read more
Close monitoring and individualizing treatment plans should be top priorities for the multidisciplinary teams caring for women who are pregnant or are considering pregnancy and exhibiting signs of pulmonary hypertension, according to new research published in International Journal of Cardiology Congenital Heart Disease.1 This patient population is known to have higher risks of maternal morbidity … Read more